Matches in Wikidata for { <http://www.wikidata.org/entity/Q66406861> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66406861 description "clinical trial" @default.
- Q66406861 description "ensayu clínicu" @default.
- Q66406861 description "klinisch onderzoek" @default.
- Q66406861 description "клінічне випробування" @default.
- Q66406861 name "A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer" @default.
- Q66406861 name "A Continuation Study of Herceptin" @default.
- Q66406861 type Item @default.
- Q66406861 label "A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer" @default.
- Q66406861 label "A Continuation Study of Herceptin" @default.
- Q66406861 prefLabel "A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer" @default.
- Q66406861 prefLabel "A Continuation Study of Herceptin" @default.
- Q66406861 P1132 Q66406861-E20CFA45-C175-4573-A988-BEBD75E79A7B @default.
- Q66406861 P1476 Q66406861-C4FEC004-43C7-4BCF-9C60-63422D20184C @default.
- Q66406861 P17 Q66406861-0277F91A-1A59-41D3-B7E7-7E495D9DEE48 @default.
- Q66406861 P17 Q66406861-0B937B06-B648-41A1-8581-EF58DDC2918B @default.
- Q66406861 P17 Q66406861-16CD707B-ACAA-453F-94AC-04680D4155FE @default.
- Q66406861 P17 Q66406861-2265D2E8-AAB7-4010-A1EE-CEC51D7D2B3E @default.
- Q66406861 P17 Q66406861-3CE4DE66-FFE0-471A-B6DC-E05855AC0A54 @default.
- Q66406861 P17 Q66406861-42E2B88E-6954-4082-A98E-DB85C6A42D20 @default.
- Q66406861 P17 Q66406861-511A5F37-4FBE-4215-B191-C4CBB93F031F @default.
- Q66406861 P17 Q66406861-534C552E-4B8E-4A5E-BFE1-6EC7DAD9AE81 @default.
- Q66406861 P17 Q66406861-5754ADC3-C787-4E40-B70B-4910B234AB1D @default.
- Q66406861 P17 Q66406861-7A589010-6F51-42E6-9254-87BAED64EF02 @default.
- Q66406861 P17 Q66406861-836C020E-1D9F-47FB-8F38-4F772DE4360F @default.
- Q66406861 P17 Q66406861-ABE05D57-8E0B-4F50-B4B0-8657E9D2F385 @default.
- Q66406861 P17 Q66406861-B0E4524E-D36E-40FB-9447-B770E95CB184 @default.
- Q66406861 P17 Q66406861-D9FAE8E0-CE59-4B5F-B34B-686EBA69A263 @default.
- Q66406861 P2899 Q66406861-438D7DF4-B70B-4A19-ACFD-2948E1E743CE @default.
- Q66406861 P3098 Q66406861-EF5DBA6B-5DA7-4D71-B44B-9D13F7FC9147 @default.
- Q66406861 P31 Q66406861-FAA35A12-999F-4E97-A2D9-1D733C07F5F6 @default.
- Q66406861 P580 Q66406861-B1F2D08C-4631-437B-ABED-70337149078A @default.
- Q66406861 P582 Q66406861-B9987171-651B-4C8A-BB48-0ACB719CEFF4 @default.
- Q66406861 P6099 Q66406861-AD42CAD4-B027-45D6-8A8C-AD7144606A69 @default.
- Q66406861 P8363 Q66406861-343CC91D-7623-4CC7-8706-6DD19B449DA8 @default.
- Q66406861 P859 Q66406861-A3EAD073-FFAA-4419-8E09-F6F69A2D37E4 @default.
- Q66406861 P1132 "+69" @default.
- Q66406861 P1476 "A Single Arm, Multi-Center, International, Continuation Trial of Recombinant Humanized Antibody Herceptin (Trastuzumab) in Patients With HER2-Overexpressing Tumors" @default.
- Q66406861 P17 Q142 @default.
- Q66406861 P17 Q145 @default.
- Q66406861 P17 Q183 @default.
- Q66406861 P17 Q28 @default.
- Q66406861 P17 Q29 @default.
- Q66406861 P17 Q31 @default.
- Q66406861 P17 Q36 @default.
- Q66406861 P17 Q403 @default.
- Q66406861 P17 Q408 @default.
- Q66406861 P17 Q45 @default.
- Q66406861 P17 Q664 @default.
- Q66406861 P17 Q774 @default.
- Q66406861 P17 Q801 @default.
- Q66406861 P17 Q804 @default.
- Q66406861 P2899 "+18" @default.
- Q66406861 P3098 "NCT02721641" @default.
- Q66406861 P31 Q30612 @default.
- Q66406861 P580 "1999-06-01T00:00:00Z" @default.
- Q66406861 P582 "2015-02-01T00:00:00Z" @default.
- Q66406861 P6099 Q42824827 @default.
- Q66406861 P8363 Q78089383 @default.
- Q66406861 P859 Q212646 @default.